As uncertainty hangs over the availability of Vertex’s cystic fibrosis drug in England, the company has signed an agreement that gives Danish patients access to Orkambi. The access contract, agreed by Vertex and the Danish pharmaceutical and procu...
Original Article: Denmark funds Vertex's CF drug Orkambi, UK talks deadlocked